Summary Administration of 5-aminolaevulinic acid (ALA) leads to porphyrin accumulation in malignant and premalignant tissues, and ALA is used as a prodrug in photodynamic therapy (PDT). To understand the mechanism of porphyrin accumulation after the administration of ALA and to investigate whether ALA-induced protoporphyrin IX Correspondence to: FWM de Rooij lead to the development of adenocarcinoma through a multistep process of progression from metaplasia to lo%--agrade dysplasia.
activit-y of (Rubino and Rasetti. 1966 : Schoenfeld et al. 1988a : Navone et al. 1990 . 1991 : el-Sharabasx et al. 1992 . and in most studies these cells have been found to have a decreased FC activitv (Rubino and Rasetti. 1966 : Dailex and Smith. 1984 : Smith. 1987 : el-Sharabasv et al. 1992 : Van Hillegersberg et al. 1992 ). For such cells. administration of ALA will lead to the accumulation of porphyrins. especially PPIX (Anderson et al. 1981 ). This provides a biological rationale for the clinical use of ALA photodynamic therapy (ALA-PDT).
Barrett's (columnar-lined) oesophagus results from long-term gastro-oesophageal reflux (Mossberg. 1966) . It is of clinical importance because of its malignant potential. Barrett's oesophagus can high-grade dysplasia and ultimately to invasixe cancer (Hamilton and Smith. 1987: Hameeteman et al. 1989) . High-grade dysplasia in Barrett's oesophagus presents a difficult management problem.
Options include endoscopic sun eillance and/or oesophagectomr (Lexine et al. 1993 : Clark et al. 1996 : Cameron. 1997 . A new nonsurgical management option involhes eradicating the dysplastic epithelium and columnar mucosa by PDT. In contrast to other photosensitizers. mans of which localize in the microxvasculature of all tissue layers of hollow organs. ALA induces much higher levels of PPIX in the mucosa than submucosa or muscularis mucosae (Loh et al. 1993 ). ALA-PDT has been used to treat high-grade dy splasia in Barrett's oesophagus. resulting in necrosis of dysplastic mucosa with regeneration of normal squamous mucosa (Gossner et al. 1995 : Reaula et al. 1995 : Barr et al. 1996 .
To optimize ALA-PDT for Barrett's oesophagus and early carcinoma. knowledae of the mechanism of porphyrin accumulation in these tissues is required. We determined the activities of PBG-D and FC in normal tissue as well as in malignant and premalignant tissue of the human oesophagrus. These tw o enzymes play an important role after the administration of ALA: PBG-D is in many cells the rate-limiting enzyme w-hen exogenous ALA is administered and FC is the enzN-me directly responsible for the conx ersion of PPIX to haem. We propose the use of a PDT power index for the intertissue variation in the abilitv to accumulate PPIX. in order to create a parameter that might indicate the susceptibilitv of tissues to ALA-PDT. (Hinnen et al, 1997a, b) . Owing to individual patient and tissue variations in the activities of PBG-D and FC, also described by others (Rubino and Rasetti. 1966: Dailey and Smith, 1984; Schoenfeld et al, 1987 , 1988ab: Smith, 1987 Navone et al. 1990; el-Sharabasy et al. 1992; Van Hillegersberg et al. 1992) , the activity of these two haem enzymes can be better described relative to each other. This ratio. which we propose to call the PDT power index, reflects the enzymatic ability of cells to accumulate porphyrins after ALA administration and might predict the susceptibility of tissue to ALA-PDT. The PDT power index was significantly increased in Barrett's epithelium and adenocarcinoma compared with normal squamous epithelium. indicating that the FC activity was relatively low compared with the PBG-D activity. As this index can also be derived from biopsy specimens, e.g. oesophagus or Barrett, it could be applied before ALA-PDT to estimate tissue susceptibility. Increased PBG-D activity relative to normal tissue has consistently been found in tumours (Schoenfeld et al. 1988a : Navone et al, 1990 , 1991 el-Sharabasy et al. 1992) as well as in rapidly dividing cells. e.g. regenerating liver cells (Schoenfeld et al, 1987 (Schoenfeld et al, . 1988b , suggesting that this phenomenon might be common in situations of increased cell replication. In contrast to the consistent studies concerning the activity of PBG-D. there seems to be a difference in FC activity among different tumour types (Rubino and Rasetti. 1966; Dailey and Smith, 1984: Smith. 1987; el-Sharabasy et al, 1992; Van Hillegersberg et al, 1992) . Dailey and Smith (1984) found a decreased FC activity in the Morris hepatoma model; however, they also pointed out that some porphyrins can act as inhibitors of FC. Smith (1987) found decreased FC activities in human skin tumours but also in normal skin tissue compared with those in rat liver mitochondria. El-Sharabasy et al (1992) determined the FC activity in whole-blood samples of children and adults with acute lymphoblastic leukaemia (ALL). non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD) and found lowered activities in patients with ALL, slightly decreased activities and increased activities of FC in blood of patients with NHL and HD respectively compared with healthy control groups. Compared with liver, which is one of the main haem-synthesizing tissues. most tissues have low enzyme activities (Webber et al. 1997) . Our group found the FC activity to be decreased in a colon carcinoma liver metastasis model and we suggested applying ALA-PDT to patients with these liver metastases (Van Hillegersberg et al, 1992) . Regarding the effect of the storage temperature on FC activity. interpretation of data from other studies might be biased because of differences in tissue storage.
In the gastrointestinal tract, accumulation of porphyrins after ALA administration is more pronounced in the mucosa than in the underlying submucosa and muscle layers. making ALA suitable for treating most mucosal lesions (Bedwell et al. 1992 : Loh et al. 1993 : Webber et al. 1997 . In patients with familial adenomatous polyposis, no differences in PPIX concentrations were found between normal and adenomatous tissue (Mlkvy et al, 1995) . In the DMH rat colonic tumour model the same group showed differences in the levels of PPIX between normal mucosa and tumour with a ratio of 1:6 (Bedwell et al. 1992) . In another study they showed that higher doses of ALA (60 mg kg' instead of 30 mg kg') improved the tumour-normal mucosa PPIX sensitization ratio in patients with British Journalof Cancer (1998) 78(5), [679] [680] [681] [682] colon carcinoma (Regula et al. 1995) . Webber et al (1997) showed selective accumulation of PPIX in adenocarcinomas of the gastrointestinal tract in 42 patients. Our biochemical study has characterized the enzymatic capacities of haem biosynthesis in normal. premalignant and malignant tissue of the human oesophagus. These results provide evidence for the selectivity of PPIX accumulation between normal and neoplastic tissue of the oesophagus. Whether selective PPIX accumulation creates the possibility of achieving selective necrosis is still in question. Recently. Bown and Millson (1997) have stated that the selectivity of ALA-PDTinduced necrosis. in the gastrointestinal tract. is between mucosa and underlying submucosa and muscularis and not between normal mucosa and neoplastic mucosa.
In conclusion. our study supports the use of ALA for selective PDT in Barrett's oesophagus and early carcinoma. Information about the PDT power index could be useful in predicting the effect of ALA administration on porphyrin accumulation and therefore on the susceptibility of the disorder to ALA-PDT.
